Literature DB >> 23306961

Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases.

Céline Chappé1, Laurent Riffaud, Catherine Tréguier, Béatrice Carsin-Nicol, David Veillard, Dan Cristian Chiforeanu, Jacques Grill, Didier Frappaz, Nicolas André, Fréderic Millot, Matthieu Vinchon, Nicolas Sirvent, Christine Edan.   

Abstract

BACKGROUND AND
PURPOSE: Gliomatosis cerebri (GC) is a rare neoplasm including a variety of tumors, with extremely variable evolution and heterogeneity of prognosis. It may appear either de novo or after a focal glioma, involve predominantly the white or the gray matter, and concern either pediatric or adult patients. We focused on primary GC involving exclusively gray matter in a pediatric population in order better to define the presentation and outcome of this disease. PATIENTS AND METHODS: We reviewed the databases of seven Departments of Pediatric Oncology to identify pediatric cases of GC between 1990 and 2007. Patients were included if they demonstrated a diffuse infiltrative process involving gray matter in magnetic resonance imaging (MRI) and histological tissue analyses, confirming a proliferative glial disorder.
RESULTS: Fourteen patients with a median age of 8 years were identified. Epilepsy was the main presenting symptom. Brain MRI showed a lesion of the temporal and insular cerebral cortex associated with tumoral infiltration of the thalami and the basal ganglia. Histological examination confirmed the diagnosis of high-grade glioma. Prognosis was always very gloomy in the short term, with a median survival of less than a year.
CONCLUSION: This rare entity, whose prognosis is appalling whatever the treatment proposed, should be clearly identified within the heterogeneous group of GC in the same way as diffuse intrinsic pontine gliomas have been identified among brain stem tumors. Systematic biopsies appear essential to permit the molecular studies which will assist in guiding the choice of future targeted treatments.

Entities:  

Mesh:

Year:  2013        PMID: 23306961     DOI: 10.1007/s00381-012-2016-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Gliomatosis cerebri: better definition, better treatment.

Authors:  Marc C Chamberlain
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

2.  Gliomatosis cerebri, imaging findings of 12 cases.

Authors:  P Desclée; D Rommel; D Hernalsteen; C Godfraind; B de Coene; G Cosnard
Journal:  J Neuroradiol       Date:  2010-03-23       Impact factor: 3.447

3.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

4.  Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

Authors:  S H Torp
Journal:  Clin Neuropathol       Date:  2002 Nov-Dec       Impact factor: 1.368

5.  Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.

Authors:  J Haapasalo; A Mennander; P Helen; H Haapasalo; J Isola
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.

Authors:  G Kaloshi; R Guillevin; N Martin-Duverneuil; F Laigle-Donadey; D Psimaras; Y Marie; K Mokhtari; K Hoang-Xuan; J-Y Delattre; M Sanson
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

7.  Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.

Authors:  Gregory T Armstrong; Peter C Phillips; Lucy B Rorke-Adams; Alexander R Judkins; A Russell Localio; Michael J Fisher
Journal:  Cancer       Date:  2006-10-01       Impact factor: 6.860

8.  Gliomatosis cerebri: report of 3 cases.

Authors:  Jason F Harrison; Hope T Richard; Ty W Abel; Jeffrey S Sosnowski; Anthony M Martino
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

9.  Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database.

Authors:  Johannes E A Wolff; Carl Friedrich Classen; Sabine Wagner; Rolf-Dieter Kortmann; Shana L Palla; Torsten Pietsch; Joachim Kühl; Astrid Gnekow; Christof M Kramm
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

Review 10.  Gliomatosis cerebri presenting as intractable epilepsy during early childhood.

Authors:  M T Jennings; M Frenchman; T Shehab; M D Johnson; J Creasy; K LaPorte; W D Dettbarn
Journal:  J Child Neurol       Date:  1995-01       Impact factor: 1.987

View more
  5 in total

1.  Gliomatosis cerebri mimicking viral encephalitis in a 4-year-old child.

Authors:  Mark William McCusker; Mary Aoife McDonald; Seamus Looby; Mary King
Journal:  BMJ Case Rep       Date:  2014-04-09

2.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

3.  Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.

Authors:  Alberto Broniscer; Omar Chamdine; Scott Hwang; Tong Lin; Stanley Pounds; Arzu Onar-Thomas; Sheila Shurtleff; Sariah Allen; Amar Gajjar; Paul Northcott; Brent A Orr
Journal:  Acta Neuropathol       Date:  2016-01-07       Impact factor: 17.088

Review 4.  Gliomatosis Cerebri: Current Understanding and Controversies.

Authors:  Surabhi Ranjan; Katherine E Warren
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244

5.  Necrotic ulcerated and bleeding striae distensae following bevacizumab in a palliative setting for gliobastomatosis cerebri.

Authors:  Olivia Laugier; Laetitia Padovani; Arnauld Verschuur; Caroline Gaudy-Marqueste; Nicolas André
Journal:  Ecancermedicalscience       Date:  2017-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.